Compare · ELV vs EXAS
ELV vs EXAS
Side-by-side comparison of Elevance Health Inc. (ELV) and Exact Sciences Corporation (EXAS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and EXAS operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $84.97B, about 7.0x EXAS ($12.19B).
- Over the past year, ELV is up 3.3% and EXAS is up 91.4% - EXAS leads by 88.1 points.
- ELV has hit the wire 13 times in the past 4 weeks while EXAS has been quiet.
- EXAS has more recent analyst coverage (25 ratings vs 23 for ELV).
- Company
- Elevance Health Inc.
- Exact Sciences Corporation
- Price
- $391.27+0.64%
- $104.94+1.02%
- Market cap
- $84.97B
- $12.19B
- 1M return
- +5.19%
- +1.60%
- 1Y return
- +3.29%
- +91.39%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 13
- 0
- Recent ratings
- 23
- 25
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)
Latest EXAS
- SEC Form 15-12G filed by Exact Sciences Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Exact Sciences Corporation
- SEC Form POSASR filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation